The first confirmed cases of West Nile virus (WNV) in the Western Hemisphere were reported in the state of New York in 1999. Since then, the virus has spread throughout the eastern and central United States and continues to extend westward. This report describes clinical signs and microscopic lesions associated with WNV infection in a Suffolk ewe and an alpaca, 2 species in which the disease has not been reported previously. In late August 2002, a 4.5-year-old female alpaca developed an acute onset of clinical signs characterized by torticollis, hyperesthesia, ataxia, recumbency, and altered mentation. The animal died 3.5 days after the onset of clinical signs. Microscopic examination of the brain revealed a mild to moderate, diffuse, lymphoplasmacytic meningoencephalitis. In early September 2002, a 3-year-old Suffolk ewe developed a rapidly progressive illness characterized by ataxia and convulsions. The apparent duration from onset of clinical signs until death was less than 8 hours. The ewe had a moderate, diffuse, lymphoplasmacytic meningoencephalitis with focal gliosis. Reverse transcription-polymerase chain reaction assays and immunohistochemistry on the brain were positive for WNV in both animals. These cases demonstrate that WNV is capable of causing sporadic, fatal, nonsuppurative meningoencephalitis in alpacas and sheep.
West Nile virus (WNV) is a mosquito-borne flavivirus that is indigenous to Africa, Asia, Europe, and Australia. 1 Birds are the natural reservoir hosts, and WNV is maintained in nature in a mosquito-bird-mosquito transmission cycle. 1 The first confirmed cases of WNV in the Western Hemisphere were reported in the state of New York in 1999. 1, 7, 11, 13 Since then, the virus has spread throughout the eastern and central United States and continues to extend westward. 1, 4, 11 The list of susceptible species identified in the United States include man, horses, dogs, cats, bats, chipmunks, skunks, rabbits, raccoons, squirrels, and more than 94 species of birds. 4, 9 This report describes fatal WNV encephalitis in an alpaca and Suffolk ewe, 2 species in which the disease has not been reported previously.
In late August 2002, torticollis was observed in an ambulatory 4.5-year-old female alpaca. Attempts to straighten the animal's neck resulted in apparent pain accompanied by vocalization. Within 24 hours the animal developed ataxia and hyperesthesia, became recumbent, and was no longer alert. Cervical radiographs failed to reveal any abnormalities. Three and a half days after clinical signs were initially observed, the animal developed respiratory distress and died. Treatment with flunixin meglumine, amoxicillin, vitamin E and selenium, corticosteroids, dimethyl sulfox- ide, and fluids did not appear to affect the clinical course of the disease.
This alpaca was the only animal affected on a farm in south-central Minnesota that had approximately 200 New World camelids (65% llamas and 35% alpacas). Animals were maintained on pasture with access to commercial llama chow and alfalfa hay. The animal was necropsied by the referring veterinarian. The only gross lesion reported was petchial hemorrhages on the surface of both kidneys.
Formalin-fixed brain, heart, liver, lung, kidney, spleen, intestine, and colon from the alpaca were routinely processed, sectioned at 5 m, and stained with hematoxylin and eosin. Mild to moderate, diffuse lymphoplasmacytic meningoencephalitis was present in all sections of the brain, including brain stem, cerebellum, and cerebrum, and consisted of perivascular cuffs 1-6 cell layers thick involving cerebral and meningeal vessels (Fig. 1 ). The perivascular cuffs were composed predominantly of lymphocytes with lesser numbers of plasma cells and large histiocytic cells. Moderate, diffuse, pulmonary congestion and edema were also identified as were small to moderately sized multifocal epicardial hemorrhages.
In early September 2002, a 3-year-old Suffolk ewe was reported to ''stumble and fall'' around noon. The animal got up and appeared normal for a time. By 6 PM, the ewe was ataxic and had apparent convulsions. The attending veterinarian administered flunixin meglumine and a tranquilizer, but the ewe died at approximately 7 PM. The apparent duration from onset of clinical signs until death was less than 8 hours. The ewe, Brain was the only tissue submitted from the ewe. Microscopic examination revealed a severe, diffuse, lymphoplasmacytic meningoencephalitis in all sections of the brain, including brain stem, cerebellum, and cerebrum, and consisted of perivascular cuffs 2-10 cell layers thick involving cerebral and meningeal vessels. The perivascular cuffs were composed predominantly of lymphocytes with lesser numbers of plasma cells and scattered macrophages (Fig. 2) . Scattered foci of gliosis were also evident.
Immunohistochemistry (IHC) for WNV was performed as described previously. 2 West Nile virus IHC on sections of alpaca brain revealed intense cytoplasmic staining in widely scattered neurons and axons in the brain stem but not in other regions of the brain. West Nile virus IHC on the ewe brain revealed numerous positive neurons and axons in the brain stem ( Fig. 3) . Intense staining was also identified in Purkinje cells, granule cells, and neurons in the granule cell layer in the cerebellum.
Significant bacteria were not isolated from brain or brain stem of either animal. Direct fluorescent antibody tests were negative for rabies virus. Fluorescence of the cortical lamina was not observed with ultraviolet illumination of fresh or fixed brain. Calcium and magnesium levels in aqueous humor of the ewe were normal. Reverse transcription-polymerase chain reaction assays were conducted at the Iowa State University Veterinary Diagnostic Laboratory 6 (Ames, IA) and the National Veterinary Services Laboratories, 5 (Ames, IA) as described previously. Reverse transcriptionpolymerase chain reaction assays were positive for WNV in both the alpaca and ewe.
The most common clinical signs observed in horses with WNV include paresis, ataxia, recumbency, and muscle fasciculation. 8, 10, 12, 13 Although the torticollis described in this alpaca was unusual, the clinical signs (ataxia and recumbency) and disease progression were similar to reported cases of fatal WNV encephalomyelitis in horses. 12, 13 The clinical course in the ewe was more rapid than is typically described in horses. More abundant WNV antigen was demonstrated with IHC in the brain of the ewe than in the alpaca or is generally observed in positive horses evaluated at this laboratory. This would suggest the possibility that more severe and widespread viral involvement in the central nervous system was responsible for the rapid clinical course in the ewe. Microscopic brain lesions in horses with WNV meningoencephalitis include nonsuppurative perivascular cuffs, gliosis, neuronal degeneration, and neuronophagia. 2, 3 Both animals in this report had a moderate to severe, lymphoplasmacytic meningoencephalitis. Gliosis and neuronal degeneration were not evident in the alpaca. Multiple small foci of gliosis were identified in the ewe.
This report documents WNV meningoencephalitis in an alpaca and Suffolk ewe. The 2 animals described in this report were the only members of their herd/ flock to exhibit clinical signs, as is typically reported with horses. 13 These cases demonstrate that WNV is capable of causing sporadic, fatal, lymphoplasmacytic meningoencephalitis in alpacas and sheep.
